mrna-1083
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Apr 14, 2023 (NCT05827926)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06864143 | Phase 2 | Mar 7, 2025 | Moderna Therapeutics |
| NCT06508320 | Phase 2 | Jul 15, 2024 | Moderna Therapeutics |
| NCT06097273 | Phase 3 | Oct 19, 2023 | Moderna Therapeutics |
| NCT05827926 | Phase 1/Phase 2 (Phase 2) | Apr 14, 2023 | Moderna Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Moderna Therapeutics | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1